Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial

Minoo Mohraz, Hamed Hosseini, Seyyed‐Hadi Ghamari et al.|BMJ|2023

Cited by 17